Clinical Trials

ICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (APEX-03)

Beijing InnoCare Pharma Tech Co., Ltd.